News 2020-01-27
Porton team will be in 2019 DCAT Week
Porton team will be in 2019 DCAT Week, come and meet our senior management and business representatives at Vanderbilt Suite of The Intercontinental Barclays, NYC. To learn more about how our global expertise, technologies and API CDMO services can help you develop impactful solutions!
Others
More
News 2025-07-31
Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology
Metal catalytic and DoE technologies for the optimization of CT1812 synthesis routes
News 2025-07-31
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.
